Filing Details
- Accession Number:
- 0001209191-23-054567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-06 18:02:02
- Reporting Period:
- 2023-11-02
- Accepted Time:
- 2023-11-06 18:02:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746298 | Scott Richard Struthers | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-02 | 918 | $9.28 | 136,440 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-02 | 918 | $29.95 | 135,522 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-11-03 | 199,082 | $9.28 | 334,604 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-03 | 199,082 | $30.56 | 135,522 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2023-11-02 | 918 | $0.00 | 918 | $9.28 |
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2023-11-03 | 199,082 | $0.00 | 199,082 | $9.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 363,823 | 2028-05-24 | No | 4 | M | Direct | |
| 164,741 | 2028-05-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 630,805 | Indirect | By Family Trust 1 |
| Common Stock | 1,000 | Indirect | By Spouse |
| Common Stock | 90,000 | Indirect | By Family Trust 2 |
| Common Stock | 90,000 | Indirect | By Family Trust 3 |
| Common Stock | 90,000 | Indirect | By Family Trust 4 |
Footnotes
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $30.56 per share. The range of sales prices on the transaction date was $29.95 to $31.37 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Billionaire Hedge Funds
